Evaluation of medication compliance in patients on antidepressants at an outpatient tertiary cancer center setting

Journal of Oncology Pharmacy Practice

Volumn 17, Issue 2, 2011, Pages 131-135

  Lal, Lincy S ^a   Hung, Frank ^a   Chun Feng, ^a   Zhuang, Amy ^a   Dacosta Byfield, Stacey ^b   Miller, Lesley Ann ^c   Adamus, Andrea ^a   Arbuckle, Rebecca ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Health Economics and Outcomes Research   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

antidepressant usage; cancer; compliance; medication procession ratio

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; ARTICLE; CANCER CENTER; COMORBIDITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

AGED; ANTIDEPRESSIVE AGENTS; CANCER CARE FACILITIES; DEPRESSION; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEOPLASMS; NORTRIPTYLINE; OUTPATIENT CLINICS, HOSPITAL; RETROSPECTIVE STUDIES; TEXAS;

EID: 79960548662     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/1078155209360874     Document Type: Article

References (11)

1. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care. Baltimore: John Hopkins University Press, 1979.
2. Hess LM, Raebel MA, Conner DA, Malone DC Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006 ; 40: 1280-8. (Pubitemid 44204957)
3. Masand PS, Roca M., Turner MS, Kane JM Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Prim Care Companion J Clin Psychiatry 2009 ; 11 (4). 147-54.
4. Vestbo J., Anderson JA, Calverley PM, Celli B., Ferguson GT, Jenkins C. et al. Adherence to inhaled therapy, mortality, and hospital admission in COPD. Thorax 2009 ; 64 (11). 939-43.
5. Ziller V., Kalder M., Abert US, Holzhauer W., Ziller M., Wagner U. et al. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol 2009 ; 20 (3). 431-6.
6. Ruddy K., Mayer E., Patridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 2009 ; 59 (1). 56-66.
7. Patridge AH, Avorn J., Wang PS, Winer EP Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002 ; 94: 652-61. (Pubitemid 34552485)
8. Valeberg BT, Miaskowski C., Hanestad BR, Bjordal K., Moum T., Rustoen T. et al. Prevalence rates for and predictors of self-reported adherence of oncology outpatients with analgesic medications. Clin J Pain 2008 ; 24: 627-36.
9. Kirk MC, Hudis CA Insight into barriers against optimal adherence to oral hormonal therapy in women with breast cancer. Clin Breast Cancer 2008 ; 8 (2). 155-61. (Pubitemid 351655930)
10. Watson M., Haviland JS, Greer S., Davidson J., Bliss JM Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999 ; 354: 1331-6. (Pubitemid 29481628)
11. Prieto JM, Atala J., Blanch J., Carreras E., Rovira M., Cirera E. et al. Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol 2005 ; 23: 6063-71.